DE69620745D1 - Pyrroloazepin-derivate - Google Patents
Pyrroloazepin-derivateInfo
- Publication number
- DE69620745D1 DE69620745D1 DE69620745T DE69620745T DE69620745D1 DE 69620745 D1 DE69620745 D1 DE 69620745D1 DE 69620745 T DE69620745 T DE 69620745T DE 69620745 T DE69620745 T DE 69620745T DE 69620745 D1 DE69620745 D1 DE 69620745D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- chem
- group
- bond
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33571495 | 1995-12-01 | ||
JP4692896 | 1996-02-09 | ||
PCT/JP1996/003522 WO1997020845A1 (en) | 1995-12-01 | 1996-12-02 | Pyrroloazepine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69620745D1 true DE69620745D1 (de) | 2002-05-23 |
DE69620745T2 DE69620745T2 (de) | 2002-10-31 |
Family
ID=26387089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69620745T Expired - Fee Related DE69620745T2 (de) | 1995-12-01 | 1996-12-02 | Pyrroloazepin-derivate |
Country Status (12)
Country | Link |
---|---|
US (4) | US5962448A (de) |
EP (1) | EP0807632B1 (de) |
JP (1) | JP3563076B2 (de) |
KR (1) | KR19980701788A (de) |
AT (1) | ATE216388T1 (de) |
AU (1) | AU719230B2 (de) |
CA (1) | CA2212092A1 (de) |
DE (1) | DE69620745T2 (de) |
ES (1) | ES2179218T3 (de) |
HU (1) | HUP9900672A3 (de) |
IL (1) | IL121432A (de) |
WO (1) | WO1997020845A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2212092A1 (en) | 1995-12-01 | 1997-06-12 | Makoto Shibata | Pyrroloazepine derivatives |
JPH10251258A (ja) * | 1997-03-14 | 1998-09-22 | Suntory Ltd | ピロロアゼピン系化合物 |
JPH11193290A (ja) | 1997-12-26 | 1999-07-21 | Suntory Ltd | ピロールスルホンアミド系化合物 |
JPH11193289A (ja) * | 1997-12-26 | 1999-07-21 | Suntory Ltd | ピロールスルホンアミド誘導体 |
ES2220396T3 (es) * | 1999-02-17 | 2004-12-16 | Daiichi Suntory Pharma Co., Ltd. | Farmacos terapeuticos para la claudicacion intermitente que comprenden pirroloazepinas. |
EP1152003B1 (de) * | 1999-12-16 | 2004-03-03 | Daiichi Suntory Pharma Co., Ltd. | Verfahren zur herstellung von optisch aktiven pyrroloazepinderivaten |
FR3008975A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU2018289303B2 (en) | 2017-06-20 | 2023-12-21 | Imbria Pharmaceuticals, Inc. | Compositions and methods for increasing efficiency of cardiac metabolism |
CA3105428A1 (en) * | 2018-07-23 | 2020-01-30 | Sumitomo Dainippon Pharma Co., Ltd. | Condensed lactam derivative |
US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
CN113788777B (zh) * | 2021-09-07 | 2023-04-11 | 华中科技大学 | 一种制备1-取代-3-羰基吡咯的方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2419119A (en) * | 1943-07-02 | 1947-04-15 | Westinghouse Electric Corp | Apparatus for treating and storing meat |
US2545491A (en) * | 1945-10-25 | 1951-03-20 | American Instr Co Inc | Apparatus for precision control of climatic conditions |
US2825680A (en) * | 1953-03-31 | 1958-03-04 | Niagara Blower Co | Apparatus for concentrating aqueous solutions of hygroscopic organic substances |
US3424231A (en) * | 1967-03-23 | 1969-01-28 | Andrew Truhan | Environmental chamber |
US3415313A (en) * | 1967-06-12 | 1968-12-10 | Niagara Blower Co | Apparatus for producing air at widely different temperatures and relative humidities |
US3671273A (en) * | 1968-05-20 | 1972-06-20 | Alec C Gunter | Apparatus for preparing a cocoa concentrate |
US3617699A (en) * | 1969-03-10 | 1971-11-02 | Donald F Othmer | A system for electrically heating a fluid being transported in a pipe |
US4103508A (en) * | 1977-02-04 | 1978-08-01 | Apple Hugh C | Method and apparatus for conditioning air |
FR2578842B1 (fr) | 1985-03-15 | 1987-04-10 | Rhone Poulenc Sante | Nouveaux derives de la pyrrolo(1,2-a) azepinone, leur preparation et les compositions pharmaceutiques qui les contiennent |
JPS62161786A (ja) * | 1986-01-08 | 1987-07-17 | Mitsubishi Chem Ind Ltd | ピロ−ル化合物 |
US4769998A (en) * | 1986-04-25 | 1988-09-13 | Advantage Electronics, Incorporated | Precision-controlled water chiller |
DK170506B1 (da) * | 1987-09-03 | 1995-10-02 | Glaxo Group Ltd | Pyrido- og azepino-indolforbindelser, fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende dem samt anvendelse af forbindelserne |
DE68926553T2 (de) * | 1988-08-02 | 1996-10-17 | Glaxo Group Ltd., London | Lactamderivate |
JP3198117B2 (ja) * | 1990-02-07 | 2001-08-13 | サントリー株式会社 | ピロロアゼピン誘導体 |
JPH0525128A (ja) * | 1990-05-11 | 1993-02-02 | Suntory Ltd | ピロロアゼピン誘導体の製造方法 |
CA2093631C (en) * | 1991-08-07 | 2003-09-23 | Akira Mizuno | Pyrroloazepine derivative |
ATE236163T1 (de) * | 1991-08-07 | 2003-04-15 | Suntory Ltd | Pyrroloazepinverbindungen |
US5544275A (en) * | 1993-03-17 | 1996-08-06 | Applied Materials, Inc. | Electrically heated fluid carrying conduit having integrated heating elements and electrical conductors |
JP3714685B2 (ja) * | 1994-05-18 | 2005-11-09 | 第一サントリーファーマ株式会社 | ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体 |
EP0771790B1 (de) * | 1995-11-02 | 2003-10-01 | Daiichi Suntory Pharma Co., Ltd. | Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten |
CA2212092A1 (en) | 1995-12-01 | 1997-06-12 | Makoto Shibata | Pyrroloazepine derivatives |
JPH10251258A (ja) | 1997-03-14 | 1998-09-22 | Suntory Ltd | ピロロアゼピン系化合物 |
JPH11193289A (ja) | 1997-12-26 | 1999-07-21 | Suntory Ltd | ピロールスルホンアミド誘導体 |
-
1996
- 1996-12-02 CA CA002212092A patent/CA2212092A1/en not_active Abandoned
- 1996-12-02 IL IL12143296A patent/IL121432A/xx not_active IP Right Cessation
- 1996-12-02 DE DE69620745T patent/DE69620745T2/de not_active Expired - Fee Related
- 1996-12-02 WO PCT/JP1996/003522 patent/WO1997020845A1/ja active IP Right Grant
- 1996-12-02 AT AT96939340T patent/ATE216388T1/de active
- 1996-12-02 ES ES96939340T patent/ES2179218T3/es not_active Expired - Lifetime
- 1996-12-02 EP EP96939340A patent/EP0807632B1/de not_active Expired - Lifetime
- 1996-12-02 JP JP52115297A patent/JP3563076B2/ja not_active Expired - Fee Related
- 1996-12-02 US US08/875,495 patent/US5962448A/en not_active Expired - Fee Related
- 1996-12-02 KR KR1019970705185A patent/KR19980701788A/ko active IP Right Grant
- 1996-12-02 AU AU76558/96A patent/AU719230B2/en not_active Ceased
- 1996-12-02 HU HU9900672A patent/HUP9900672A3/hu unknown
-
1999
- 1999-05-17 US US09/312,713 patent/US6258805B1/en not_active Expired - Fee Related
-
2001
- 2001-03-09 US US09/801,816 patent/US6489473B2/en not_active Expired - Fee Related
-
2002
- 2002-07-03 US US10/188,234 patent/US6713634B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5962448A (en) | 1999-10-05 |
WO1997020845A1 (en) | 1997-06-12 |
IL121432A0 (en) | 1998-01-04 |
US20020072515A1 (en) | 2002-06-13 |
KR19980701788A (ko) | 1998-06-25 |
US6258805B1 (en) | 2001-07-10 |
US6713634B2 (en) | 2004-03-30 |
IL121432A (en) | 2000-09-28 |
DE69620745T2 (de) | 2002-10-31 |
EP0807632A1 (de) | 1997-11-19 |
EP0807632B1 (de) | 2002-04-17 |
HUP9900672A2 (hu) | 1999-06-28 |
US20030166926A1 (en) | 2003-09-04 |
EP0807632A4 (de) | 1998-12-09 |
US6489473B2 (en) | 2002-12-03 |
JP3563076B2 (ja) | 2004-09-08 |
CA2212092A1 (en) | 1997-06-12 |
AU7655896A (en) | 1997-06-27 |
ATE216388T1 (de) | 2002-05-15 |
AU719230B2 (en) | 2000-05-04 |
HUP9900672A3 (en) | 2001-11-28 |
ES2179218T3 (es) | 2003-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE216388T1 (de) | Pyrroloazepin-derivate | |
NO990227L (no) | Heterocykliske forbindelser som farmas°ytika | |
DE69118082D1 (de) | Imidazolderivate, starke und selektive Angiotensin-II-Rezeptor-Antagonisten | |
ES2105099T3 (es) | Derivados de imidazopiridina condensados con actividad psicotropica. | |
ES2063452T3 (es) | Preparacion y uso de esteres y derivados de n-yodopropargil oxicarbonil aminoacido como agentes antimicrobianos. | |
ES2095855T3 (es) | Derivados de tetrahidrobencimidazol. | |
MX9101232A (es) | Derivados de benceno,piridina y pirimidina | |
ES2074719T3 (es) | Derivados de nucleosido de pirimidina. | |
EP0371805A3 (de) | Piperidin-Derivate und diese enthaltende Hypotensiva | |
DK0595111T4 (da) | Carbazolonderivater og fremgangsmåde til deres fremstilling | |
PE25998A1 (es) | DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS | |
WO1999033840A3 (en) | Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action | |
NO174848C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte | |
KR920004392A (ko) | 플루오로에틸캄프토테신 유도체 | |
DK0613896T3 (da) | Fremgangsmåde til fremstilling af sulfonylurinstofderivater | |
ES2087173T3 (es) | Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas. | |
ES2109936T3 (es) | Derivados de piperacina. | |
DE69303847D1 (de) | Indolderivate | |
DE69303352D1 (de) | Verfahren zur Herstellung 5-Pyrazolomerkaptan-Derivate und dessen zwischenprodukte | |
DE69834853D1 (de) | 1H-pyrrolo i1,2-böi1,2,4ötriazolederivate, Zwischenprodukte und Verfahren zur Herstellung von 1H-1,2,4,-triazol-5-yl Essigsäureesterderivate | |
MX9706123A (es) | Derivados de pirazolil-benzoilo. | |
KR940002252A (ko) | 우수한 항균작용을 갖는 신규한 피리돈 카르복실산 유도체 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP |
|
8339 | Ceased/non-payment of the annual fee |